PMC3352204_01
The course of antiretroviral therapy, chemotherapy, CD4 cells counts and viral load measurements over time.
2047-783X-14-1-42-1.jpg
PMC3352204_01_2047-783X-14-1-42-1.jpg
F1
The patient's HIV-1 viral load increased transiently during interruption of HAART, but reintroduction of therapy was soon followed by a good response (Figure 1). HIV plasma viral load. However, during this follow-up his CD4 cell count did not rise above 200/mm3 (Figure 1).